Variant report
Variant | nsv818348 |
---|---|
Chromosome Location | chr5:41572722-41579718 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs589757 | chr5:41572722-41572723 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs562165051 | chr5:41572730-41572731 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541995907 | chr5:41572859-41572860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541218530 | chr5:41572860-41572861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150288733 | chr5:41572911-41572912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75614352 | chr5:41572912-41572913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551402738 | chr5:41572932-41572933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569608484 | chr5:41572962-41572963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143315125 | chr5:41572974-41572975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191296892 | chr5:41572996-41572997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548628703 | chr5:41573016-41573017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183589386 | chr5:41573017-41573018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534457171 | chr5:41573019-41573020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551118532 | chr5:41573020-41573021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547947253 | chr5:41573021-41573022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545497794 | chr5:41573031-41573032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116816911 | chr5:41573047-41573048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72758374 | chr5:41573057-41573058 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs75768238 | chr5:41573070-41573071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144904827 | chr5:41573071-41573072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537450048 | chr5:41573102-41573103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13185010 | chr5:41573104-41573105 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs188427821 | chr5:41573120-41573121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574160770 | chr5:41573126-41573127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73750198 | chr5:41573127-41573128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs559465479 | chr5:41573155-41573156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75076458 | chr5:41573163-41573164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545243984 | chr5:41573205-41573206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563254001 | chr5:41573225-41573226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530757607 | chr5:41573238-41573239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76267655 | chr5:41573275-41573276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192421085 | chr5:41573287-41573288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528156457 | chr5:41573313-41573314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144659647 | chr5:41573341-41573342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553291912 | chr5:41573354-41573355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566235329 | chr5:41573396-41573397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs648014 | chr5:41573418-41573419 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs113441081 | chr5:41573433-41573434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114115387 | chr5:41573448-41573449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577981815 | chr5:41573461-41573462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377341096 | chr5:41573474-41573475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs684130 | chr5:41573480-41573481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs138621361 | chr5:41573505-41573506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116879233 | chr5:41573545-41573546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs36005067 | chr5:41573574-41573575 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs548859320 | chr5:41573579-41573580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563505176 | chr5:41573602-41573603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537515238 | chr5:41573609-41573610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577727911 | chr5:41573637-41573638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558247701 | chr5:41573647-41573648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 18929564 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:41572400-41572800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:41572800-41573000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:41573000-41574200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:41574200-41575000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:41575000-41575400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:41575000-41576200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr5:41575000-41576200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr5:41575200-41576000 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr5:41575200-41576000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:41575200-41576000 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr5:41575200-41576000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr5:41575200-41576200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr5:41575200-41576400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr5:41575400-41576000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:41575400-41576000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr5:41575400-41576000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr5:41575400-41576200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr5:41575400-41576200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr5:41575400-41576400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr5:41576200-41577800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr5:41577800-41578400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |